GH1 and obesity due to melanocortin 4 receptor deficiency: In the upcoming years, we can assume that patients whose care has been coordinated by the Reference Center, with multidisciplinary care and GH treatment starting very early on in life, will display less obesity and fewer life-threatening comorbidities.